Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: A potential role for platelet dysfunction

Psychosomatic Medicine

Volumn 74, Issue 8, 2012, Pages 873-877

  Fontoura, Paula C ^a   Pinto, Vivian Liane Mattos ^a   Matsuura, Cristiane ^a   Resende, Angela De C ^a   De Bem, Graziele F ^a   Ferraz, Marcos R ^a   Cheniaux, Elie ^a,b   Brunini, Tatiana Marlowe C ^a   Mendes Ribeiro, Antônio Cláudio ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

bipolar disorder; nitric oxide; oxidative stress; platelet

Indexed keywords

AMINO ACID; ARGINASE; C REACTIVE PROTEIN; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR EUTHYMIA; BIPOLAR MANIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE DYSFUNCTION;

EID: 84867276994     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3182689460     Document Type: Article

References (22)

1. Ebmeier KP. Managing bipolar disorder in primary care. Practitioner 2010; 254:19-22, 2.
2. Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001;58: 844-50.
3. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007;68:899-907.
4. Garcia-Portilla MP, Saiz PA, Bascaran MT, Martinez AS, Benabarre A, Sierra P, Torres P, Montes JM, Bousono M, Bobes J. Cardiovascular risk in patients with bipolar disorder. J Affect Disord 2009;115:302-8.
5. Van der Kooy K, Van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007;22:613-26.
6. Canan F, Dikici S, Kutlucan A, Celbek G, Coskun H, Gungor A, Aydin Y, Kocaman G. Association of mean platelet volume with DSM-IV major depression in a large community-based population: the MELEN study. J Psychiatr Res 2012;46:298-302.
7. Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost 2009;7:573-81.
8. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482-94.
9. Palmer RM, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endotheliumdependent relaxation. Biochem Biophys Res Commun 1988;153:1251-6.
10. Mendes Ribeiro AC, Brunini TM, Yaqoob M, Aronson JK, Mann GE, Ellory JC. Identification of system y+L as the high-affinity transporter for L-arginine in human platelets: up-regulation of L-arginine influx in uraemia. Pflugers Arch 1999;438:573-5.
11. Yanik M, Vural H, Tutkun H, Zoroglu SS, Savas HA, Herken H, Kocyigit A, Keles H, Akyol O. The role of the arginineYnitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 2004;254:43-7.
12. Hoekstra R, Fekkes D, Pepplinkhuizen L, Loonen AJ, Tuinier S, Verhoeven WM. Nitric oxide and neopterin in bipolar affective disorder. Neuropsychobiology 2006;54:75-81.
13. Garća RG, Zarruk JG, Barrera C, Pinzón A, Trillos E, Arenas WD, Luengas C, Tomaz C, López-Jaramillo P. Plasma nitrate levels and flowmediated vasodilation in untreated major depression. Psychosom Med 2011;73:344-9.
14. Morris SM Jr. Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 2009;157:922-30.
15. Moss MB, Siqueira MA, Mann GE, Brunini TM, Mendes-Ribeiro AC. Platelet aggregation in arterial hypertension: is there a nitric oxideYurea connection Clin Exp Pharmacol Physiol 2010;37:167-72.
16. Kunz M, Gama CS, Andreazza AC, Salvador M, Cereser KM, Gomes FA, Belmonte-de-Abreu PS, Berk M, Kapczinski F. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1677-81.
17. Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, Selek S, Tutkun H, Zoroglu SS, Akyol O. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 2006;7:51-5.
18. Morao I, Periyasamy G, Hillier IH, Joule JA. The role of tetrahydrobiopterin in catalysis by nitric oxide synthase. Chem Commun (Camb) 2006; 33:3525-7.
19. Selek S, Savas HA, Gergerlioglu HS, Bulbul F, Uz E, Yumru M. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 2008;107:89-94.
20. Gergerlioglu HS, Savas HA, Bulbul F, Selek S, Uz E, Yumru M. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:697-702.
21. Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, Ferrara F, Novo S. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 2010;17:1-11.
22. Brietzke E, Kapczinski F. TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1355-61.